Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
5/17/2023 | $9.50 | Neutral | Piper Sandler |
1/25/2023 | Buy → Neutral | Compass Point | |
8/30/2022 | $13.25 | Mkt Perform | Keefe Bruyette |
4 - Blue Foundry Bancorp (0001846017) (Issuer)
RUTHERFORD, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank (the "Bank"), reported a net loss of $11.9 million, or $0.55 per diluted common share, for the year ended December 31, 2024 compared to a net loss of $7.4 million, or $0.31 per diluted common share for the year ended December 31, 2023. The Company reported a net loss of $2.7 million, or $0.13 per diluted common share, for the three months ended December 31, 2024 compared to a net loss of $4.0 million, or $0.19 per diluted common share for the three months ended September 30, 2024, and a net loss of $2.9 million, or $0.13 per diluted common share
RUTHERFORD, N.J., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank, announced that on the morning of Wednesday, January 29, 2025 it will release financial results for the quarter ended December 31, 2024. A copy of the earnings release will be available on the Company's website, https://ir.bluefoundrybank.com/, in the "News" section and on the SEC's website, https://www.sec.gov/. Representatives of the Company will hold a conference call for investors and analysts on Wednesday, January 29, 2025 at 11:00AM (ET) to discuss the Fourth Quarter and Year-End 2024 Earnings. Blue Foundry Bancorp will address live questi
RUTHERFORD, N.J., Oct. 23, 2024 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank (the "Bank"), today reported a net loss of $4.0 million, or $0.19 per diluted common share, for the three months ended September 30, 2024, compared to net loss of $2.3 million, or $0.11 per diluted common share, for the three months ended June 30, 2024, and a net loss of $1.4 million, or $0.06 per diluted common share, for the three months ended September 30, 2023. James D. Nesci, President and Chief Executive Officer, commented, "The Company continues to maintain its strong capital position and access to liquidity. We executed on our share repu
RUTHERFORD, N.J., July 23, 2024 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), announced today the appointment of John F. Kuntz, Esq. as a Director of both the Company and its subsidiary, Blue Foundry Bank, effective immediately. Kenneth Grimbilas, Chairman, stated, "We are very pleased to have Mr. Kuntz join Blue Foundry's Board of Directors. His extensive knowledge and experience in financial, legal and operational matters will provide additional perspective and depth to the organization. His experience with charitable foundations will also prove to be instrumental at Blue Foundry." Mr. Kuntz most recently served as Senior Executive Vice President and Chief Adm
RUTHERFORD, N.J., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), announced today the appointment of Elizabeth Varki Jobes, Esq. as a Director, effective immediately. James D. Nesci, President and Chief Executive Officer stated, "We are excited to welcome Ms. Jobes to Blue Foundry's Board of Directors. Her years of combined legal and compliance experience leading large, global companies will bring additional perspective to our Board and will prove to be instrumental at Blue Foundry." Ms. Jobes serves as Senior Vice President and Global Chief Compliance Officer of Amryt Pharmaceuticals, a global commercial-stage pharmaceutical company, since 2020. Bef
SCHEDULE 13G/A - Blue Foundry Bancorp (0001846017) (Subject)
8-K - Blue Foundry Bancorp (0001846017) (Filer)
10-Q - Blue Foundry Bancorp (0001846017) (Filer)
RUTHERFORD, N.J., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank (the "Bank"), reported a net loss of $11.9 million, or $0.55 per diluted common share, for the year ended December 31, 2024 compared to a net loss of $7.4 million, or $0.31 per diluted common share for the year ended December 31, 2023. The Company reported a net loss of $2.7 million, or $0.13 per diluted common share, for the three months ended December 31, 2024 compared to a net loss of $4.0 million, or $0.19 per diluted common share for the three months ended September 30, 2024, and a net loss of $2.9 million, or $0.13 per diluted common share
RUTHERFORD, N.J., Jan. 15, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the "Company"), the holding company for Blue Foundry Bank, announced that on the morning of Wednesday, January 29, 2025 it will release financial results for the quarter ended December 31, 2024. A copy of the earnings release will be available on the Company's website, https://ir.bluefoundrybank.com/, in the "News" section and on the SEC's website, https://www.sec.gov/. Representatives of the Company will hold a conference call for investors and analysts on Wednesday, January 29, 2025 at 11:00AM (ET) to discuss the Fourth Quarter and Year-End 2024 Earnings. Blue Foundry Bancorp will address live questi
RUTHERFORD, N.J., Nov. 12, 2024 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ: BLFY), the holding company for Blue Foundry Bank, announced that as of November 7, 2024, it had completed its fourth stock repurchase program and had adopted another program to repurchase up to 1,139,420 shares of its common stock, which is approximately 5% of its outstanding common stock. The program commenced on November 8, 2024. This is the Company's fifth stock repurchase program since completing its mutual-to-stock conversion and related stock offering in July 2021. Since announcing its first stock repurchase program on July 20, 2022, through the completion of the fourth stock repurchase program, th
Piper Sandler initiated coverage of Blue Foundry Bancorp with a rating of Neutral and set a new price target of $9.50
Compass Point downgraded Blue Foundry Bancorp from Buy to Neutral
Keefe Bruyette initiated coverage of Blue Foundry Bancorp with a rating of Mkt Perform and set a new price target of $13.25
4 - Blue Foundry Bancorp (0001846017) (Issuer)
4 - Blue Foundry Bancorp (0001846017) (Issuer)
4 - Blue Foundry Bancorp (0001846017) (Issuer)
SC 13G/A - Blue Foundry Bancorp (0001846017) (Subject)
SC 13G/A - Blue Foundry Bancorp (0001846017) (Subject)
SC 13G/A - Blue Foundry Bancorp (0001846017) (Subject)